Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders

The use of convalescent plasma (CP) from individuals recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a promising therapeutic modality for the coronavirus disease 2019 (COVID-19). CP has been in use for at least a century to provide passive immunity against a number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanza, Francesco, Agostini, Vanessa, Monaco, Federica, Passamonti, Francesco, Seghatchian, Jerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486975/
https://www.ncbi.nlm.nih.gov/pubmed/34820612
http://dx.doi.org/10.2991/chi.k.210403.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486975/
https://www.ncbi.nlm.nih.gov/pubmed/34820612
http://dx.doi.org/10.2991/chi.k.210403.001

Ejemplares similares